Immunotherapy against environmental fungi causing respiratory allergy

Umut Gazi1, Nerin Nadir Bahceciler2

  • 1Department of Medical Microbiology and Clinical Microbiology, Faculty of Medicine, Near East University, Nicosia, Cyprus.

PubMed

Insights

Allergen specific immunotherapy (AIT) shows promise for allergic fungal airway diseases (AFADs), but more research is needed. This review focuses on Alternaria and Cladosporium AIT efficacy and immunological findings.

Area of Science:

  • Environmental Science
  • Allergy and Immunology
  • Public Health

Background:

  • Allergic respiratory diseases (ARDs) are a growing global health concern.
  • Fungal spores from Alternaria, Cladosporium, Penicillium, and Aspergillus are common triggers for allergic fungal airway diseases (AFADs).
  • Current research on allergen specific immunotherapy (AIT) for AFADs is limited.

Purpose of the Study:

  • To review current literature on AIT for AFADs, focusing on Alternaria and Cladosporium.
  • To highlight the public health importance of AFADs due to environmental factors.
  • To summarize immunological findings to aid future research.

Main Methods:

  • Comprehensive literature review of clinical studies on AIT for AFADs.
  • Focus on studies involving Alternaria and Cladosporium immunotherapy.
  • Analysis of immunological data related to mould-AIT.

Main Results:

  • Limited studies currently evaluate AIT efficacy specifically for AFADs.
  • Alternaria and Cladosporium AIT show potential but require further investigation.
  • Immunological insights from mould-AIT are crucial for therapeutic development.

Conclusions:

  • There is a need for more robust clinical trials on AIT for AFADs.
  • Understanding immunological responses can help predict treatment outcomes.
  • Addressing AFADs is critical given rising environmental challenges.

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
353
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
240
Allergic Reactions02:06

Allergic Reactions

Overview
27.2K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
222
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
359
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K